Science 37
The Site Operations Manager I leads the clinical study management team to ensure the on-time and on-budget delivery of clinical studies while maintaining the highest quality standards. This role serves as the primary point of contact for client study teams and oversees all operational aspects of clinical trials in compliance with corporate SOPs, GCP/ICH guidelines, and applicable regulations. The position is responsible for end-to-end execution of clinical trials, including planning, execution, and close-out, while managing study metrics, budgets, and cross-functional team performance.
Headquarters
Morrisville, North Carolina, United States
Company Size
501-1000 employees
Founded
2014
Science 37 is the industry-leading patient access company and the first and only FDA-inspected Direct-to-Patient clinical trial site, dedicated to expanding clinical trial enrollment through patient- and site-centric solutions. The company brings clinical research directly to patients' homes using a team of 150+ research-grade nurses, broadly licensed investigators, and results-based patient recruitment services. Science 37 partners with sponsors and CROs across a wide range of therapeutic areas to accelerate enrollment, improve participant diversity, and deliver high-quality trial execution beyond the geographic limits of traditional sites.
Science 37 Honored for Site Innovation in the 2025 Clinical Trials Arena Excellence Awards
Dec 1, 2025
Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes
1 month ago
Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards
Jan 7, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Science 37.
Science 37 didn’t post a salary, so this is our estimate from similar listings.
eMed to buy Science 37 for $38 million
Aug 4, 2025
Decentralized trial company Science 37 to be acquired by eMed in $38M deal
Jan 29, 2024